Announcements Trials
Browse Landscape

Phase

Phase 2 139Phase 1 97Phase 1/2 58Phase 3 26Phase 4 11Phase NA 3Phase EARLY_PHASE1 2Phase 2/3 1

Status

Recruiting 2Completed 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neuroma, Acoustic 1Neurofibromatosis 2 1Meningioma 1Glioma 1Glioblastoma 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 23Metformin 14pembrolizumab 12Radiotherapy 12Biopsy 11Nivolumab 9Fluorouracil 9Cyclophosphamide 9Temozolomide 7Radiation 7Bevacizumab 7gallium 68 PSMA-11 6Sirolimus 6Rituximab 6Letrozole 6Etoposide 6Cisplatin 6Aspirin 6olaparib 5Surveys and Questionnaires 5Radiosurgery 5Oxaliplatin 5Irinotecan 5Indocyanine Green 5Granulocyte Colony-Stimulating Factor 5Fluorodeoxyglucose F18 5Dexamethasone 5aldesleukin 4Surgical Procedures, Operative 4Proflavine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Completed × Everolimus × Clear all
NCT03834740 2025-05-30

A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection

St. Joseph's Hospital and Medical Center, Phoenix

Phase EARLY_PHASE1 Completed
27 enrolled 17 charts
CNS

Brain Neoplasms, Glioblastoma, Glioma

NCT01880749 2020-05-13

Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas

NYU Langone Health

Phase EARLY_PHASE1 Completed
5 enrolled
CNS

Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡